May, 2013
BGI Health signed cooperation agreement with S.R.L, the largest medical testing organization in India, to introduce the NIFTY test, cancer genetic tests and other genetic tests to India.
April, 2013
BGI Health Asia-Pacific team participated in the 2013 Human Genome Meeting and 21st International Congress of Genetics. Prof. Qi Ming and Dr. Zhang Lei gave excellent speeches on genomic research and clinical services in BGI. The meeting greatly enhanced BGI’s reputation in Southeast Asia and laid foundation for BGI’s local development.
April 2013
Dr. T. P. Baskaran accepted the invitation to be an honorary professor of BGI Health. As a highly respected regional leader in fetal medicine, Dr. Baskaran is helping to build up a network between maternal fetal medicines professionals in Malaysia and BGI Health.

April 11th, 2013
The delegates from Chulalongkorn Hospital, one of the top public hospitals in Thailand, visited BGI in Shenzhen. Prof. Dhiraphongs and Dr. Saknan discussed with BGI Health team about the collaboration on Newborn screening and other genetic diagnosis, together with the development of genomic applications in clinical medicine.
April, 2013
DNA Laboratories from Malaysia visited BGI in Shenzhen. CEO Dr. WONG Yongwee and Marketing Director Mr. Calvin Thien had a discussion on the collaboration details in reproductive and fetal health, as well as other clinical services.
April, 2013
BGI Health signed cooperation agreement to work with IVIOMICS from Spain in India, to promote the development and application of NIFTY service in north India, especially IVF hospitals.
March, 2013
BGI Health signed cooperation agreement with Srushti Hospital, one of the most famous Institute in India for reproductive medicine, to promote the development and application of NIFTY in south India, especially IVF hospitals.
March, 2013
BGI Health signed cooperation agreement with Metropolis, one of the biggest third-party clinical testing providers in India, aimed to introduce advanced genetic testing technology into India, to improve the reproductive health level of local residents.
March, 2013
The Eastern Biotech & Life Science in UAE co-organized with BGI Health for the launch seminar of NIFTY service in Dubai, and over a hundred local OB/GYN doctors participated. Dr. Ying LIU, the Marketing Director of BGI Asia-Pacific team, presented to the participants a variety of genetic tests provided by BGI, especially NIFTY. BGI Asia intends to reduce the incidence of birth defects and other genetic diseases in Middle East by introducing the most advanced genetic tests in local population. Genome web news link:http://www.genomeweb.com//node/1207906?hq_e=el&hq_m=1539296&hq_l=1&hq_v=ff9fa2f28c
March 4th, 2013
The delegates from Siriraj Hospital visited BGI. Siriraj Hospital is the largest public hospital in Thailand and the delegates signed a MOU with BGI on providing high quality medical services in Thailand.

February, 2013
INEX signed a strategic cooperation agreement with Primary Healthcare Limited, starting to promote BGI’s NIFTY services in seven states, especially major cities including Sydney, Melbourne, Brisbane, Adelaide, and Perth. Primary Health Care is one of the top medical companies in Australia, with 87 medical centers, 87 pathology laboratories and 782 sample collection centers. Through Laverty Pathology in Sydney, Dorevitch Pathology in Melbourne, QML pathology in Brisbane and Western Diagnostic in Perth, Primary Health Care is providing NIFTY service in Australia as iGeneScreen.
February, 2013
BGI Health was invited to exhibit and present sequencing-based genetic tests at the Jordan National Obstetrics and Gynecology Conference.


January, 2013
BGI Health Asia-Pacific team was invited to the International Conference on Next Evolution in Genetics and Genomics in New Delhi. Dr. Ying LIU, senior scientist and marketing director, gave an enlightening speech on NIFTY test.
October, 2012
Dr. Faruq, CEO of UAE Eastern Biotech & Life Science visited BGI, and reached a strategic cooperation agreement with BGI on genetic testing of monogenic diseases, thalassemia and hereditary tumors. 
September, 2012
BGI COO Mr. Yin Ye signed a cooperation agreement with INEX INNOVATIONS EXCHANGE in Singapore, aiming to promote women’s reproductive health in Southeast Asia. The non-executive director, Professor Mahesh Choolani is the top OB/GYN specialist in Singapore and the whole AP region and also an honorary professor of BGI.
September, 2012
BGI Health participated in India ISPAT Annual Meeting, and gave two presentations on our progress of NIFTY and Monogenic Diseases. The participation of BGI Health had greatly enhanced BGI’s image and laid foundation for local collaborations.

August, 2012
Rak Luke Maganize in Thailand reported the launch of NIFTY test in Thailand.
July, 2012
The first third-party testing laboratory in Thailand, Bangkok R.I.A LAB.C0.,LTD. (Bria lab), signed contract with BGI for NIFTY distribution in Thailand.
June, 2012
 BGI signed contract with Malaysia Fetal Genome Sdn Bhd, to promote NIFTY service in Malaysia.
June, 2012
Dr. Ying LIU, the Marketing Director of Asia-Pacific team, and Miss Shanshan Tang, the Sales Director, were invited to visit Erbil, Iraq and signed cooperation agreement with the Excellent Company in Iraq, aiming to introduce the most advanced genetic technology to Iraq.

April, 2012
BGI Diagnosis Asia-Pacific team participated in the 2012 Vietnam maternity medical congress. BGI Sales Director, Ms. Shanshan Tang, gave an inspiring speech on prenatal genetic testing.
March 9th2012
The delegates from the National Hospital for Obstetrics and Gynecology in Vietnam visited BGI.


February, 2012
BGI signed cooperation agreement with INEX (Inex Innovations Exchange), one of the top diagnostic products providers on gynecological health in Singapore. BGI authorizes INEX to promote NIFTY service in Australia, aiming to reduce the incidence of birth defects in Australia with the most reliable, secure and accurate genetic testing services.